Clinical Trials Browser

Nausea, Vomiting

Breast Neoplasms

Nausea With Vomiting Chemotherapy-Induced

Nausea, Pain, Vomiting

Nausea, Vomiting, Hematologic Neoplasms

Nausea, Neoplasms, Vomiting

Gastrointestinal Neoplasms, Vomiting

Nausea, Vomiting

Solid Tumors

Breast Neoplasms, Nausea, Vomiting

Neoplasms, Vomiting

Breast Neoplasms, Nausea, Vomiting, Breast Neoplasms, Male

Colonic Neoplasms, Nausea, Rectal Neoplasms, Vomiting, Colorectal Neoplasms

Nausea, Neoplasms, Vomiting

Nausea, Neoplasms, Vomiting

Lymphoma, Multiple Myeloma, Nausea, Neoplasms

Multiple Myeloma

Neoplasms, Vomiting

Breast Neoplasms, Nausea, Vomiting, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

Genital Neoplasms, Female, Nausea, Vomiting

Nausea, Sarcoma, Vomiting

Neoplasms, Vomiting

Hematologic Diseases, Leukemia, Nausea, Vomiting, Leukemia, Myeloid, Acute, Hematologic Neoplasms

Anorexia, Melanoma, Nausea, Vomiting, Weight Loss

Lymphoma, Non-Hodgkin, Vomiting

Leukemia, Lymphoma, Nausea, Vomiting

Clinical Trials

APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer

Treatment of Refractory Nausea and Vomiting in Patients With Breast Cancer

Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy

Buccal Film Versus IV Injection Palonosetron for Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting

ProTreat

Effect of SAR302503 on ECG Activity in Patients With Solid Tumors

Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy

CINV

Netupitant and Palonosetron Hydrochloride in Preventing Chronic Nausea and Vomiting in Patients With Cancer

CINV

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Netupitant and Palonosetron Hydrochloride in Preventing Chemotherapy Induced Nausea and Vomiting in Patients With Cancer Undergoing BEAM Conditioning Regimen Before Stem Cell Transplant

Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer

MEDEA

Intravenous Palonosetron With Radiotherapy and Concomitant Temozolomide

GIM15-NEPA

An Efficacy and Safety Study of Intravenous Palonosetron Administered as an Infusion and as a Bolus for the Prevention of Nausea and Vomiting

RAPA

Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast Cancer

Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOX

Palonosetron in Moderately and Highly Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04935)(COMPLETED)

Palonosetron Plus Dexamethasone in Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04594)

Multi-day Doses in Prevention of Nausea and Emesis

Safety and Efficacy Study for the Prevention of Nausea and Vomiting in Multiple Myeloma Patients Receiving Stem Cell Transplantation.

Efficacy of Thalidomide in Preventing Chemotherapy-induced Delayed Nausea and Vomiting

The Efficacy and Safety of Palonosetron in Preventing the Gastrointestinal Reactions Induced by 3-day Highly Emetogenic Chemotherapy

Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical Trial

GAND-emesis

Pharmacokinetic Evaluation of Subcutaneous Versus Intravenous Palonosetron in Cancer Treated With Chemotherapy

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Ondansetron Versus Palonosetron Antiemetic Regimen Prior to Highly Emetogenic Chemotherapy(HEC)

Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI)

ESPNV

Palonosetron Versus Ondansetron for the Prevention of Nausea and Vomiting

Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting

NHLPal

AMENO-2

An Efficacy and Safety Study of Palonosetron in Preventing Chemotherapy-Induced Nausea and Vomiting (CINV) in the Chinese Cancer Patients